HEST

Venture Capitalhest.group

HEST is a Dallas-based venture capital family office founded in 2023 that invests in early-stage startups across life sciences, biotechnology, cybersecurity, and deep technology, backing visionary founders through direct equity capital.

Company typePrivate
Founded2023
HeadquartersDallas, United States
Headcount—
GTM typeB2B
OfferingServices

What HEST does

HEST is a Dallas-based venture capital family office founded in 2023 that invests in early-stage startups across four stated verticals: life sciences, biotechnology, cybersecurity, and deep technology. Operating under the trade names HEST Ventures and Hest Group, the firm is headquartered at 8222 Douglas Ave., Ste. 250, Dallas, TX 75225, and targets "visionary founders" building companies the firm believes can "revolutionize their industries and reshape the future." The single core offering is direct equity investment into early-stage companies, with no externally disclosed fund vehicles, AUM, or limited-partner base in the supplied data.

The firm's disclosed portfolio comprises at least nine companies spanning therapeutics (Secretome Therapeutics, Immunome, CourageTx, QanaTX), deep tech and consumer applications (Valerion, Ambit at ambit.inc, Claimreturn, Infinite Youth), and a more mature space asset (SpaceX). HEST sources deal flow primarily through its own digital infrastructure — a corporate website (hest.group), a dedicated pitch intake address ([email protected]), and general/press contact channels ([email protected], [email protected]) — and describes its GTM as a sales-led direct-investment motion targeting founders.

Operationally, HEST is a small private entity with one named executive (Rich Haut, President) and four disclosed open positions as of the careers page capture: Financial Analyst, Market Research, Chief Financial Officer, and Market Advisor, all based in Dallas. The firm does not disclose investment cadence, check sizes, ownership stakes, fund structure, or realized returns; its technology stack and core platform comprise a standard WordPress-based website and email channels rather than proprietary investment infrastructure. As a family office, revenue is principally derived from portfolio investment outcomes rather than recurring product sales.

HEST firmographics

Firmographics

Name: HEST
Legal name: HEST
Website: https://hest.group
Company type: Private
Founded year: 2023
Operating status: Operating
Short description: HEST is a Dallas-based venture capital family office founded in 2023 that invests in early-stage startups across life sciences, biotechnology, cybersecurity, and deep technology, backing visionary founders through direct equity capital.
Ownership category
akta.pro rank

HEST industry classification

Industry

Product category: Venture Capital
NAICS: All Other Financial Investment Activities (52399), Other Financial Investment Activities (5239)
SIC: Investment Advice (6282)
akta.pro primary industry: Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
akta.pro secondary industry: Alternative Investments for Private Wealth (Hedge Funds, PE/VC Access, Private Credit) (FSAAABAI)

Keywords

Venture capital investing
Early-stage equity funding
Biotechnology investments
Cybersecurity venture capital
Deep tech startup funding

Where HEST is headquartered

Location

Headquarters

HQ city: Dallas
HQ country: United States
HQ region: North America

Offices1 record

Markets served

HEST business model

Business model

GTM type: B2B
Offering type: Services
Cost components: Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

Investment Returns / Capital Gains: HEST Ventures generates returns through equity investments in early-stage startups. Returns are realized through portfolio company exits via IPOs, acquisitions, or secondary sales. As a VC family office, the firm likely takes equity stakes in exchange for capital deployment.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

HEST product offering

Product offering

Core offering

HEST Ventures is a Dallas-based VC family office that invests equity capital in early-stage startups across life sciences, biotechnology, cybersecurity, and deep technology sectors. Founded in 2023, the firm backs visionary founders building companies that challenge the status quo and have the potential to revolutionize their industries. Returns are generated through portfolio company exits via IPOs, acquisitions, or secondary sales.

Product overview

HEST operates as a venture capital family office with a single core investment offering called HEST Ventures. The firm deploys capital into early-stage startups across four key verticals: life sciences, Biotech, Cybersecurity, and deep tech. Founded in 2023 and headquartered in Dallas, TX, the company backs founders building groundbreaking ventures that challenge the status quo. The portfolio currently includes investments in Secretome Therapeutics, Valerion, Claimreturn, Immunome, Qana, Ambit, CourageTX, SpaceX, and Infinite Youth. As a VC family office, the primary business model centers on equity investment and portfolio company support rather than a traditional product/service platform.

Differentiator

Problem solved

Functional benefit

Products and services

HEST Ventures A Dallas-based VC family office that invests equity capital in early-stage startups across life sciences, biotechnology, cybersecurity, and deep technology sectors, targeting visionary founders building companies capable of reshaping their industries.

Companies that use HEST

Customer profile

Segments3 records

Ideal customer profiles3 records

HEST technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

HEST partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

HEST competitors and assessment

Company assessment

Direct peers

ARCH Venture Partners: One of the leading early-stage biotech and life sciences VCs. Directly comparable to HEST's life sciences/biotech specialization, though much larger in scale and with a deeper track record of healthcare exits.
Founders Fund: Deep-tech and frontier-technology focused VC investing from seed to growth. Comparable on the deep tech vertical and contrarian, founder-focused thesis that HEST explicitly mirrors.
KdT Ventures: Early-stage VC focused on biotech and frontier technology startups. Comparable fund size and stage focus to HEST, especially on the biotech side of HEST's thesis.
Section 32: Biotech and tech-bio focused early-stage VC founded by Bill Maris. Directly comparable to HEST's life sciences/biotech specialization.
DCVC (Data Collective): Deep-tech-focused VC investing in computational and life sciences applications. Comparable thesis on deep tech + biotech overlap with HEST's primary segment focus.
Khosla Ventures: Multi-vertical early-stage VC with strong exposure to biotech, deep tech, and cybersecurity. Comparable breadth of sectors and early-stage orientation, though at far greater AUM scale.
Lux Capital: Sector-focused early-stage VC that invests across frontier tech, life sciences, and deep tech. Highly comparable to HEST given overlapping verticals (biotech, deep tech, cybersecurity) and early-stage, founder-focused thesis.
Artis Ventures: Early-stage VC investing at the intersection of biotech, healthtech, and frontier tech. Closely matches HEST's life sciences and deep tech verticals.

Broad incumbents

Andreessen Horowitz (a16z): Large multi-vertical tech VC with dedicated bio/health and deep tech franchises. Comparable sector breadth to HEST, but operates at much larger fund size and institutional scale.

Regional players

Perceptive Advisors: Healthcare/biotech-focused investment firm (public + private) with significant Texas presence. Comparable life sciences focus; operates in adjacent geographies (NY and US-wide) relative to HEST's Dallas base.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

HEST financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HEST leadership team

Management profile

Number of profiles

Profiles1 record

HEST funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HEST M&A and investment

M&A and investment

M&A

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HEST

What does HEST do?

Is HEST a public or private company?

HEST is a private company. It is classified as family owned and is currently operating.

When was HEST founded?

HEST was founded in 2023.

Where is HEST based?

HEST is headquartered in Dallas, United States, in the North America region.

How does HEST make money?

One revenue line is on record: investment Returns / Capital Gains.

Who are HEST's main competitors?

Direct peers on record are ARCH Venture Partners, Founders Fund, KdT Ventures, Section 32, DCVC (Data Collective), Khosla Ventures, Lux Capital and Artis Ventures. Andreessen Horowitz (a16z) is listed as a broad incumbent. Perceptive Advisors is listed as a regional player.

Does HEST have an API?

No public API is recorded for HEST.

What industry is HEST in?

HEST's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSAAABAI, Alternative Investments for Private Wealth (Hedge Funds, PE/VC Access, Private Credit). Its NAICS code is 52399 and its SIC code is 6282.